Literature DB >> 15145901

Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.

G Montalescot1, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, M T Rothman.   

Abstract

Little information is currently available from the various societies of cardiology on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Since primary PCI is the main method of reperfusion in AMI in many centres, and since of all cardiac emergencies AMI represents the most urgent situation for PCI, recommendations based on scientific evidence and expert experience would be useful for centres practising primary PCI, or those looking to establish a primary PCI programme. To this aim, a task force for primary PCI in AMI was formed to develop a set of recommendations to complement and assist clinical judgment. This paper represents the product of their recommendations.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15145901      PMCID： PMC1768296     

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  118 in total

1.  Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators.

Authors:  J J Young; D J Kereiakes; C L Grines
Journal:  J Invasive Cardiol       Date:  2000-12       Impact factor: 2.022

2.  Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention.

Authors:  J P Collet; G Montalescot; C Lesty; Z Mishal; J Soria; R Choussat; G Drobinski; C Soria; P Pinton; P Barragan; D Thomas
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

3.  A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction.

Authors:  Christophe Loubeyre; Marie-Claude Morice; Thierry Lefèvre; Jean-François Piéchaud; Yves Louvard; Pierre Dumas
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

Review 4.  The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock.

Authors:  E R Bates; R J Stomel; J S Hochman; E M Ohman
Journal:  Int J Cardiol       Date:  1998-05-29       Impact factor: 4.164

5.  Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.

Authors:  K M Anderson; R M Califf; G W Stone; F J Neumann; G Montalescot; D P Miller; J J Ferguson; J T Willerson; H F Weisman; E J Topol
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

6.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

7.  Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).

Authors:  J R Chamberlin; A B Lardi; L S McKeever; M H Wang; G Ramadurai; P Grunenwald; W P Towne; E D Grassman; F S Leya; B E Lewis; L H Stein
Journal:  Catheter Cardiovasc Interv       Date:  1999-06       Impact factor: 2.692

8.  Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.

Authors:  S G Ellis; S Ajluni; A Z Arnold; J J Popma; J A Bittl; N L Eigler; M J Cowley; R E Raymond; R D Safian; P L Whitlow
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

Authors:  E J Topol; R M Califf; B S George; D J Kereiakes; C W Abbottsmith; R J Candela; K L Lee; B Pitt; R S Stack; W W O'Neill
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245
View more
  4 in total

1.  Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience.

Authors:  G Parodi; G Memisha; R Valenti; M Trapani; A Migliorini; G M Santoro; D Antoniucci
Journal:  Heart       Date:  2005-04-06       Impact factor: 5.994

Review 2.  The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS).

Authors:  Bernhard Rauch; Constantinos H Davos; Patrick Doherty; Daniel Saure; Maria-Inti Metzendorf; Annett Salzwedel; Heinz Völler; Katrin Jensen; Jean-Paul Schmid
Journal:  Eur J Prev Cardiol       Date:  2016-10-25       Impact factor: 7.804

3.  Community-Based Physical Rehabilitation After Percutaneous Coronary Intervention for Acute Myocardial Infarction.

Authors:  Meiling Xiao; Yinjun Li; Xiaodan Guan
Journal:  Tex Heart Inst J       Date:  2021-06-01

Review 4.  Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip.

Authors:  Natalie N Khalil; Megan L McCain
Journal:  Front Cardiovasc Med       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.